Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

Cyteir Therapeutics (CYT)

Cyteir Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CYT
DateTimeSourceHeadlineSymbolCompany
07/03/202421:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CYTCyteir Therapeutics Inc
07/03/202421:30Business WireCyteir Announces Timeline for Voluntarily Delisting from NasdaqNASDAQ:CYTCyteir Therapeutics Inc
05/03/202423:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CYTCyteir Therapeutics Inc
15/02/202400:36Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CYTCyteir Therapeutics Inc
14/02/202400:14Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CYTCyteir Therapeutics Inc
27/12/202321:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CYTCyteir Therapeutics Inc
14/12/202321:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CYTCyteir Therapeutics Inc
07/12/202321:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CYTCyteir Therapeutics Inc
05/12/202321:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CYTCyteir Therapeutics Inc
22/11/202318:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CYTCyteir Therapeutics Inc
17/11/202321:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CYTCyteir Therapeutics Inc
06/11/202321:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CYTCyteir Therapeutics Inc
12/10/202321:14Edgar (US Regulatory)Form DEFM14A - Definitive proxy statement relating to merger or acquisitionNASDAQ:CYTCyteir Therapeutics Inc
12/10/202312:52Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:CYTCyteir Therapeutics Inc
12/10/202312:51Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CYTCyteir Therapeutics Inc
12/10/202312:30Business WireOngoing Results From a Dose Expansion Cohort of CYT-0851 in Combination With Capecitabine in Advanced Platinum-Resistant Ovarian Cancer Show Promising Clinical Activity and Generally Well Tolerated Safety ProfileNASDAQ:CYTCyteir Therapeutics Inc
05/10/202321:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CYTCyteir Therapeutics Inc
02/10/202321:44Edgar (US Regulatory)Form PREM14A - Preliminary proxy statements relating to merger or acquisitionNASDAQ:CYTCyteir Therapeutics Inc
07/08/202321:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CYTCyteir Therapeutics Inc
30/06/202322:29Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CYTCyteir Therapeutics Inc
30/06/202315:38Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CYTCyteir Therapeutics Inc
30/06/202315:37Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:CYTCyteir Therapeutics Inc
30/06/202315:22Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CYTCyteir Therapeutics Inc
30/06/202315:22Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CYTCyteir Therapeutics Inc
30/06/202313:00Business WireCyteir Therapeutics Announces Discontinuation of CYT-0851 Development Program and Planned Liquidation and DissolutionNASDAQ:CYTCyteir Therapeutics Inc
28/06/202323:03Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:CYTCyteir Therapeutics Inc
28/06/202323:02Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CYTCyteir Therapeutics Inc
20/06/202322:54Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CYTCyteir Therapeutics Inc
14/06/202321:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CYTCyteir Therapeutics Inc
05/06/202313:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CYTCyteir Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:CYT